Skip to main content

Maria Buti Ferret

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Maria Buti Ferret

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Carotid atherosclerosis and chronic hepatitis B: role of persistent viral suppression and immunemediated response. A prospective study.

IP: Maria Buti Ferret
Collaborators: Maria del Mar Riveiro Barciela
Funding agency: Gilead Sciences, S.L.U.
Funding: 49005
Reference: GLD16_00057
Duration: 14/12/2016 - 13/12/2018

Análisis de la interacción de los virus de la hepatitis B y D con el receptor del hepatocito y estudio prospectivo de la complejidad de sus quasiespecies virales

IP: Maria Buti Ferret
Collaborators: Lluís Viladomiu Catà, Maria del Mar Riveiro Barciela, Carolina Gonzalez Fernandez, David Tabernero Caellas
Funding agency: Instituto de Salud Carlos III
Funding: 147015
Reference: PI14/01416
Duration: 01/01/2015 - 31/12/2017

Malalties Hepatobiliars (GRC)

IP: -
Collaborators: Beatriz Minguez Rosique, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Antonio González Fernández, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Malalties Hepatobiliars (GRC), Silvia Sauleda Oliveras, Maria Buti Ferret, Josep Quer Sivila, Josep Gregori Font, Malalties Hepatobiliars (GRC), Damir Garcia Cehic, Juan Ignacio Esteban Mur, Meritxell Ventura Cots, Macarena Simon-Talero Horga, Joan Genescà Ferrer, David Tabernero Caellas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 65000
Reference: 2014 SGR 421
Duration: 01/01/2014 - 31/12/2016

Análisis de situación y estrategia de manejo de pacientes con infección crónica por VHB sin criterios de tratamiento según las guías de la Asociación Europea para el estudio del hígado

IP: Maria Buti Ferret
Collaborators: Maria del Mar Riveiro Barciela
Funding agency: Gilead Sciences, S.L.U.
Funding: 39591
Reference: GLD13/00137
Duration: 18/09/2013 - 17/09/2014

Related news

The grants, amounting to more than €533,000 for VHIR, will allow clinical duties to be partially released over three years to promote strategic research projects in obesity, respiratory diseases, aortic pathology and metabolic fatty liver disease.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

This tool will help avoid invasive techniques and assist in selecting candidates for clinical trials of new treatments.

Related professionals

Segundo Bujan Rivas

Segundo Bujan Rivas

Systemic Diseases
Read more
Federica Rizzo

Federica Rizzo

Predoctoral researcher
Stroke research
Read more
Ana Villar Gomez

Ana Villar Gomez

Main researcher
Pneumology
Read more
Éric Suárez Carrillo

Éric Suárez Carrillo

Administration and Management
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.